Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Chinese Medical Journal|July 23, 2002
Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell lineZhang Wei, Dierk Thomas, Christoph A Karle, et al.
Progress in Biophysics and Molecular Biology|July 28, 2012
The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heartAndreas A Werdich, Anna Brzezinski, Darwin Jeyaraj, et al.
Cardiovascular Research|November 13, 2004
Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X)Dierk Thomas, Bettina C Hammerling, Anna-Britt Wimmer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 16, 2010
Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapineSabrina Obers, Ingo Staudacher, Eckhard Ficker, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|February 15, 2002
Variable expression of long QT syndrome among gene carriers from families with five different HERG mutationsJesaia Benhorin, Arthur J Moss, Matthew Bak, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2004
Pentamidine-induced long QT syndrome and block of hERG traffickingYuri A Kuryshev, Eckhard Ficker, Lu Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 28, 2013
Ionic bases for electrical remodeling of the canine cardiac ventricleDarwin Jeyaraj, Xiaoping Wan, Eckhard Ficker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 2, 2010
hERG K+ channel-associated cardiac effects of the antidepressant drug desipramineIngo Staudacher, Lu Wang, Xiaoping Wan, et al.
European Journal of Pharmacology|December 7, 2007
Doxazosin induces apoptosis of cells expressing hERG K+ channelsDierk Thomas, Ramona Bloehs, Ronald Koschny, et al.
Plos One|August 24, 2012
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivoAaron Petty, Eugene Myshkin, Haina Qin, et al.
Pageof 5